Gerstein HC, Sattar N, Rosenstock J, Ramasundarahettige C, Pratley R, Lopes RD, Lam CSP, Khurmi NS, Heenan L, Del Prato S, et al: Cardiovascular and Renal Outcomes with Efpeglenatide in Type 2 Diabetes
Methylenetetrahydrofolate reductase gene germ-line C677T and A1298C SNPs are associated with colorectal cancer risk in the Turkish population
Express Scripts made Zepbound vials (tirzepatide) the preferred weight-loss GLP-1 on its 2026 National Preferred Formulary, excluding Wegovy injection and tablets as non-preferred alternatives
\Body Composition Improvements: May help increase lean body mass and reduce fat, consistent with growth hormone's effects
Eleven percent of covered workers, including 28% of covered workers at firms with 10 to 199 workers, are in a plan with a worker contribution of $12,000 or more for family coverage
Yeni yaynlanan bir aratrmann verilerine gre, Danimarkal ila firmas Novo Nordisk'in yaygn kullanlan zayflama ilac Wegovyyi ve tip 2 diyabet iin benzer ilalar kullanan hastalar, grme duyusunu tehdit eden bir gz rahatszl asndan daha yksek risk altnda olabilir
)
